TABLE 2.
MAbs used in this study
| MAba | Descriptionb | Specificityc |
|---|---|---|
| MAb 6 | Anti-S. meliloti NRG247 (Balsac) IgG3 (F2P18E) | Strain-cross-reactive |
| MAb 7 | Anti-S. meliloti NRG34 IgM (F12P92F) | Strain-specific |
| MAb 8 | Anti-S. meliloti NRG185 IgM (F4P26B) | Strain-specific |
| MAb 9 | Anti-S. meliloti NRG247 (Balsac) IgM (F12P92F) | Strain-specific |
| MAb 10 | Anti-S. meliloti NRG34 IgG3 (F12P64C) | Strain-cross-reactive |
| MAb 11 | Anti-S. meliloti NRG185 IgM (F3P49C) | Strain-cross-reactive |
a
All MAbs used in this study were obtained from P. Olsen and are described in detail elsewhere (11). The numerical designations are those used by Olsen et al. (11).
b
Each MAb was raised against whole cells of the designated strains. IgG3, immunoglobulin G3.
c
The terms “strain-cross-reactive” and “strain-specific” were used in the previous report (11).